BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2023 11:08:58 AM | Browse: 55 | Download: 101
Publication Name World Journal of Cardiology
Manuscript ID 88431
Country Greece
Received
2023-09-25 16:25
Peer-Review Started
2023-09-25 16:28
To Make the First Decision
Return for Revision
2023-11-09 04:04
Revised
2023-11-12 00:00
Second Decision
2023-11-21 01:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-11-28 08:37
Articles in Press
2023-11-28 08:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-12-21 03:02
Publish the Manuscript Online
2023-12-25 11:08
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Editorial
Article Title Inherited arrhythmias and gene therapy: Are there any ethical considerations to take into account?
Manuscript Source Invited Manuscript
All Author List Michael Spartalis, Eleftherios Spartalis and Gerasimos Siasos
ORCID
Author(s) ORCID Number
Michael Spartalis http://orcid.org/0000-0002-7442-838X
Eleftherios Spartalis http://orcid.org/0000-0003-4451-8074
Funding Agency and Grant Number
Corresponding Author Michael Spartalis, Doctor, FACC, FESC, MS, MSc, PhD, Doctor, 3rd Department of Cardiology, National and Kapodistrian University of Athens, 152 Mesogeion Ave, Athens 11527, Greece. msparta@med.uoa.gr
Key Words Arrhythmia; Sudden cardiac death; Genome editing; Long QT; Channelopathies; Mutation
Core Tip The use of genome editing to treat rhythm disturbances at the substrate level could provide a revolutionary treatment for disorders that the current standard of care is inadequate. Our knowledge of the disease is the only limit in identifying a perfect genome editing tool for several rhythm disturbances. As our understanding of gene vectors and transfer techniques progress, a novel therapy approach will be upon us, where cardiac muscles are altered to be impervious to rhythm disturbances, enhancing patients’ quality of living and relieving the burden on healthcare organizations. Ethical issues will eventually arise, as the treatments will be expensive.
Publish Date 2023-12-25 11:08
Citation Spartalis M, Spartalis E, Siasos G. Inherited arrhythmias and gene therapy: Are there any ethical considerations to take into account? World J Cardiol 2023; 15(12): 623-626
URL https://www.wjgnet.com/1949-8462/full/v15/i12/623.htm
DOI https://dx.doi.org/10.4330/wjc.v15.i12.623
Full Article (PDF) WJC-15-623-with-cover.pdf
Full Article (Word) WJC-15-623.docx
Manuscript File 88431_Auto_Edited-LJH-JLW.docx
Answering Reviewers 88431-Answering reviewers.pdf
Audio Core Tip 88431-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 88431-Conflict-of-interest statement.pdf
Copyright License Agreement 88431-Copyright license agreement.pdf
Peer-review Report 88431-Peer-review(s).pdf
Scientific Misconduct Check 88431-Bing-Liu JH-2.png
Scientific Misconduct Check 88431-CrossCheck.png
Scientific Editor Work List 88431-Scientific editor work list.pdf